OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101. A total of 43 filers reported holding OSMOTICA PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,606 | +79.0% | 272,584 | +1057.9% | 0.00% | – |
| Q2 2023 | $13,185 | +7104.9% | 23,541 | -85.3% | 0.00% | – |
| Q1 2023 | $183 | -6.2% | 160,411 | -7.8% | 0.00% | – |
| Q4 2022 | $195 | -99.9% | 173,947 | +7.2% | 0.00% | – |
| Q3 2022 | $341,000 | +424.6% | 162,228 | +237.1% | 0.00% | – |
| Q2 2022 | $65,000 | +38.3% | 48,125 | +10.5% | 0.00% | – |
| Q4 2021 | $47,000 | -87.5% | 43,560 | -65.9% | 0.00% | – |
| Q3 2021 | $376,000 | -22.0% | 127,563 | -20.3% | 0.00% | – |
| Q2 2021 | $482,000 | -63.8% | 160,140 | -61.7% | 0.00% | -100.0% |
| Q1 2020 | $1,331,000 | +394.8% | 418,646 | +496.2% | 0.00% | – |
| Q3 2019 | $269,000 | -39.7% | 70,224 | -40.2% | 0.00% | -100.0% |
| Q2 2019 | $446,000 | -48.9% | 117,373 | -51.5% | 0.00% | 0.0% |
| Q1 2019 | $872,000 | -66.0% | 242,115 | -26.9% | 0.00% | -75.0% |
| Q4 2018 | $2,568,000 | – | 331,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 14,600,444 | $1,264,399 | 1.11% |
| TITLEIST ASSET MANAGEMENT, LLC | 100,142 | $8,672 | 0.00% |
| Dakota Community Bank & Trust NA | 1,809 | $157 | 0.00% |
| Insight Advisors, LLC/ PA | 75,646 | $6,551 | 0.00% |
| NORTHERN TRUST CORP | 65,334 | $5,658 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 307,266 | $26,609 | 0.00% |
| STATE STREET CORP | 106,487 | $9,222 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 272,584 | $23,606 | 0.00% |
| MORGAN STANLEY | 32,000 | $2,771 | 0.00% |